Britta Lödén
About
In The Last Decade
Britta Lödén
14 papers receiving 250 citations
Peers
Comparison fields: 5 of 32
- Pulmonary and Respiratory Medicine 166
- Oncology 121
- Otorhinolaryngology 68
- Radiation 47
- Radiology, Nuclear Medicine and Imaging 47
Countries citing papers authored by Britta Lödén
This map shows the geographic impact of Britta Lödén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Britta Lödén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Britta Lödén more than expected).
Fields of papers citing papers by Britta Lödén
This network shows the impact of papers produced by Britta Lödén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Britta Lödén. The network helps show where Britta Lödén may publish in the future.
Co-authorship network of co-authors of Britta Lödén
This figure shows the co-authorship network connecting the top 25 collaborators of Britta Lödén. A scholar is included among the top collaborators of Britta Lödén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Britta Lödén. Britta Lödén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 38 | |
| 2 | 23 | |
| 3 | 7 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | 57 | |
| 7 | The value of induction chemotherapy for survival in patients with non-small cell lung cancer treated with radiotherapy. | 1 |
| 8 | 10 | |
| 9 | 48 | |
| 10 | Molecular profiling using tissue microarrays as a tool to identify predictive biomarkers in laryngeal cancer treated with radiotherapy. | 10 |
| 11 | Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: a phase II study from the Swedish Lung Cancer Study Group | 1 |
| 12 | 22 | |
| 13 | Multicentre phase II trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancer. | 7 |
| 14 | 23 | |
| 15 | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.